Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S N Pokrovsky

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Biomaterials, Artificial Cells, and Artificial Organs|January 1, 1990
Immunosorbents for LDL-apheresisS N Pokrovsky, Adamova IYu, G F Benevolenskaya
Artificial Organs|April 1, 1991
Immunosorbent for selective removal of lipoprotein (a) from human plasma: in vitro studyS N Pokrovsky, Adamova IYu, O Y Afanasieva, et al.
Transfusion Science|November 3, 1996
Immunosorbent for IgG apheresis: an in vitro studyE A Kiseleva, O I Afanasieva, N A Kosheleva, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|March 1, 1991
Autoantibodies against modified low density lipoprotein. Nonlipid factor of blood plasma that stimulates foam cell formationA N Orekhov, V V Tertov, A E Kabakov, et al.
Atherosclerosis. Supplements|May 5, 2015
Lowering of lipoprotein(a) level under niacin treatment is dependent on apolipoprotein(a) phenotypeN V Artemeva, M S Safarova, M V Ezhov, et al.
Kardiologiia|March 15, 2017
[Elevated Lipoprotein(a) Cncentration and Presence of Subfractions of Small Dense Low Density Lipoproteins as Independent Factors of Risk of Ischemic Heart Disease]O I Afanasieva, E A Utkina, N V Artemieva, et al.
Chemistry and Physics of Lipids|January 1, 1994
Extracorporeal immunoadsorption for the specific removal of lipoprotein (a) (Lp(a) apheresis): preliminary clinical dataS N Pokrovsky, A V Sussekov, O I Afanasieva, et al.
Artificial Organs|December 1, 1986
Low-density lipoprotein apheresis and regression of atherosclerotic plaque in vitroA N Orekhov, K A Khashimov, D N Mukhin, et al.
Circulation Research|March 1, 1988
Blood serum atherogenicity associated with coronary atherosclerosis. Evidence for nonlipid factor providing atherogenicity of low-density lipoproteins and an approach to its eliminationA N Orekhov, V V Tertov, S N Pokrovsky, et al.
Lancet (London, England)|November 17, 1984
Artificial HDL as an anti-atherosclerotic drugA N Orekhov, Misharin AYu, V V Tertov, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Biomaterials, Artificial Cells, and Artificial Organs|January 1, 1990
Immunosorbents for LDL-apheresisS N Pokrovsky, Adamova IYu, G F Benevolenskaya
Artificial Organs|April 1, 1991
Immunosorbent for selective removal of lipoprotein (a) from human plasma: in vitro studyS N Pokrovsky, Adamova IYu, O Y Afanasieva, et al.
Transfusion Science|November 3, 1996
Immunosorbent for IgG apheresis: an in vitro studyE A Kiseleva, O I Afanasieva, N A Kosheleva, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|March 1, 1991
Autoantibodies against modified low density lipoprotein. Nonlipid factor of blood plasma that stimulates foam cell formationA N Orekhov, V V Tertov, A E Kabakov, et al.
Atherosclerosis. Supplements|May 5, 2015
Lowering of lipoprotein(a) level under niacin treatment is dependent on apolipoprotein(a) phenotypeN V Artemeva, M S Safarova, M V Ezhov, et al.
Kardiologiia|March 15, 2017
[Elevated Lipoprotein(a) Cncentration and Presence of Subfractions of Small Dense Low Density Lipoproteins as Independent Factors of Risk of Ischemic Heart Disease]O I Afanasieva, E A Utkina, N V Artemieva, et al.
Chemistry and Physics of Lipids|January 1, 1994
Extracorporeal immunoadsorption for the specific removal of lipoprotein (a) (Lp(a) apheresis): preliminary clinical dataS N Pokrovsky, A V Sussekov, O I Afanasieva, et al.
Artificial Organs|December 1, 1986
Low-density lipoprotein apheresis and regression of atherosclerotic plaque in vitroA N Orekhov, K A Khashimov, D N Mukhin, et al.
Circulation Research|March 1, 1988
Blood serum atherogenicity associated with coronary atherosclerosis. Evidence for nonlipid factor providing atherogenicity of low-density lipoproteins and an approach to its eliminationA N Orekhov, V V Tertov, S N Pokrovsky, et al.
Lancet (London, England)|November 17, 1984
Artificial HDL as an anti-atherosclerotic drugA N Orekhov, Misharin AYu, V V Tertov, et al.
Pageof 3